Professor Lenka Munoz received her PhD in Medicinal Chemistry from the University of Bonn, Germany and completed a post-doctoral fellowship in molecular pharmacology at Northwestern University, USA. She started her academic career at the University of Sydney in 2011 and was promoted to Professor of Molecular Cancer Pharmacology in 2021. Prof Munoz is a Research Academic Director (Biomedical), Faculty of Medicine and Health and Head of the Glioblastoma Drug Discovery laboratory at the Charles Perkins Centre at The University of Sydney. Her research focuses on brain cancer, particularly identifying novel targets against glioblastoma, delineating the molecular mechanism of action for cancer drugs, and developing effective therapies against glioblastoma.